Supernus Pharmaceuticals Inc

Slēgts

SektorsVeselības aprūpe

47.77 1.66

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

46.6

Max

47.93

Galvenie mērījumi

By Trading Economics

Ienākumi

36M

-2.3M

Pārdošana

-3.9M

208M

EPS

0.21

Peļņas marža

-1.104

Darbinieki

778

EBITDA

-70M

20M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+30.77% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-82M

2.7B

Iepriekšējā atvēršanas cena

46.11

Iepriekšējā slēgšanas cena

47.77

Ziņu noskaņojums

By Acuity

50%

50%

163 / 342 Rangs Healthcare

Supernus Pharmaceuticals Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 1. jūl. 23:52 UTC

News
Correlated Moves
Social Media

Meta Platforms Inc. shares fell in after-market trading amid a broader tech market downturn, despite earlier gains on plans for a cloud computing business.

2026. g. 1. jūl. 23:51 UTC

Social Media
News
Correlated Moves
ETF Constituents

Invesco QQQ Trust trading lower after Nasdaq 100 decline, reflecting a market shift away from technology stocks. Notable trades occurred at $737.25.

2026. g. 1. jūl. 23:36 UTC

Correlated Moves
News

Ethereum is trading higher, buoyed by Bitcoin's recent gains. Earlier in the session, Ethereum peaked before pulling back slightly but has since regained ground.

2026. g. 1. jūl. 23:36 UTC

News
Social Media

AMD shares are higher in after-market hours following a $36 million equity award announcement for CEO Lisa T. Su and positive discussions at HPE Discover 2026.

2026. g. 1. jūl. 23:36 UTC

News
Correlated Moves

Ethereum is trading higher, supported by Bitcoin's recent strong move. It pulled back slightly from earlier session highs but remains above Tuesday's close.

2026. g. 1. jūl. 23:31 UTC

News

United States Oil Fund LP advances in after-market trading, despite lower oil prices and mixed global equity performance. No specific news identified for the move.

2026. g. 1. jūl. 23:16 UTC

Correlated Moves
News

Qualcomm Inc. shares rose in after-market trading, reflecting a modest gain since Wednesday's close, amid KLA Corp's price increase and recent index removals.

2026. g. 1. jūl. 23:06 UTC

News
ETF Constituents

Vanguard Growth ETF declines in after-market trading, reversing earlier gains. Broader market faces pressure from economic data and geopolitical tensions.

2026. g. 1. jūl. 23:06 UTC

Social Media
News
ETF Constituents

The SPDR Dow Jones Industrial Average ETF Trust declined slightly in after-market hours, reflecting broader market trends and mixed investor sentiment.

2026. g. 1. jūl. 23:06 UTC

News
Correlated Moves
ETF Constituents

The Nasdaq 100 Index shows slight gains in after-market hours, while the Vanguard Information Technology ETF remains roughly flat amid stable trading conditions.

2026. g. 1. jūl. 22:51 UTC

News

Buy rating upgrade from Guggenheim boosts CHKP in after-market.

2026. g. 1. jūl. 20:07 UTC

News
Social Media

American Airlines shares rise as Bernstein raises price target to $23. FAA's approval for supersonic flights may boost investor sentiment.

2026. g. 1. jūl. 20:07 UTC

News

The Nikkei 225 Index is lower in after-market hours, reflecting significant volatility amid broader market sell-offs in technology stocks. No specific news was identified.

2026. g. 1. jūl. 20:05 UTC

Correlated Moves
ETF Constituents
News

The iShares MSCI United Kingdom ETF is lower today amid reduced Bank of England rate hike expectations and a decline in the U.K. Manufacturing PMI.

2026. g. 1. jūl. 20:04 UTC

Macro News
Macro Event
ETF Constituents
News

The Communication Services Select Sector SPDR Fund is rising amid a broader market rally, driven by strong gains in Meta Platforms and the overall sector.

2026. g. 1. jūl. 20:04 UTC

Social Media
News
Macro Event
ETF Constituents

VanEck Gold Miners ETF declines as broader market dynamics weigh on investor sentiment, despite a rise in spot gold prices to $4,085 an ounce.

2026. g. 1. jūl. 20:04 UTC

Social Media
News
ETF Constituents

iShares China Large-Cap ETF gains amid positive sentiment following the China foreign minister's remarks on U.S. relations and strong performance from constituent stocks.

2026. g. 1. jūl. 20:04 UTC

Correlated Moves
News
Event
Macro Event
Social Media

iShares 20+ Year Treasury Bond ETF declines amid rising Treasury yields and comments from Federal Reserve Chair Kevin Warsh on high prices. The ETF went ex-dividend today at $0.31803.

2026. g. 1. jūl. 20:03 UTC

News

Piper Sandler raised Illumina's price target to $200, contributing to shares trading higher today. The company also expanded its board with a new appointment.

2026. g. 1. jūl. 20:03 UTC

Macro Event
News

Willis Towers Watson PLC launched its expanded CyMax Facility for cyber insurance aimed at SMEs in the EMEA region, boosting shares during Wednesday's session.

2026. g. 1. jūl. 20:03 UTC

News
Correlated Moves

NXP Semiconductors NV's stock is lower amid negative assessment from StockStory, citing revenue concerns and lagging growth compared to industry averages.

2026. g. 1. jūl. 20:03 UTC

Social Media
News

Adobe Inc. is trading higher during Wednesday's session, with analysts suggesting potential for recovery amid ongoing interest in the software sector despite recent challenges.

2026. g. 1. jūl. 20:03 UTC

Social Media
News

Microsoft's stock rises on a five-year partnership with Haleon to enhance AI capabilities. A Jefferies survey shows Azure gaining traction over AWS.

2026. g. 1. jūl. 20:02 UTC

News

Align Technology Inc. shares are higher as the company addresses an antitrust investigation and announces plans for its second-quarter 2026 financial results.

2026. g. 1. jūl. 20:02 UTC

Macro Event
Social Media
News

Automatic Data Processing's stock rose following the ADP National Employment Report, which showed a 98,000 increase in private sector jobs for June.

2026. g. 1. jūl. 20:02 UTC

Correlated Moves
News

Analog Devices Inc. shares are lower today, impacted by a significant decline in the semiconductor sub-sector and broader market volatility.

2026. g. 1. jūl. 19:56 UTC

Correlated Moves
News

The U.S. dollar is near two-week lows, impacting the Invesco Currencyshares Japanese Yen Trust, which is trading roughly flat amid ongoing geopolitical tensions.

2026. g. 1. jūl. 19:56 UTC

Macro Event
Correlated Moves
ETF Constituents
Macro News
News

Energy Select Sector SPDR Fund declines amid broader energy sector downturn and falling crude oil prices. ExxonMobil and Schlumberger contribute to negative performance.

2026. g. 1. jūl. 19:51 UTC

Social Media
News
Macro Event

Cognizant Technology Solutions shares rise following the launch of Cognizant Neuro AI Trust, despite HSBC lowering its price target to $68 from $80.

2026. g. 1. jūl. 19:47 UTC

Correlated Moves
Social Media
News

Alphabet Inc shares are higher as the company surpasses its $1 billion investment target in Africa, despite mixed social media sentiment regarding recent legal challenges.

Salīdzinājums

Cenas izmaiņa

Supernus Pharmaceuticals Inc Prognoze

Cenas mērķis

By TipRanks

30.77% augšup

Prognoze 12 mēnešiem

Vidējais 62 USD  30.77%

Augstākais 66 USD

Zemākais 55 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Supernus Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

3 ratings

2

Pirkt

1

Turēt

0

Pārdot

Noskaņojums

By Acuity

163 / 342 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. The company's commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset seizures in adults and children between 6 to 17 years of age. It also offers comprise Qelbree, a novel non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, the company's product candidates include SPN-830, a late-stage drug/device combination product candidate for the treatment of off episodes in PD patients; SPN-817, a novel first-in-class selective acetylcholinesterase inhibitor, which is in Phase II clinical trials for the treatment of epilepsy; SPN-820, a product candidate in Phase II clinical trials for treating resistant depression; SPN-443, a preclinical product for the treatment of ADHD/CNS; and SPN-446 for narcolepsy and SPN-448 for the treatment of CNS which is in discovery stage. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Rockville, Maryland.
help-icon Live chat